Cited by 475Platelet Disorders and TreatmentsBlood Coagulation and Thrombosis MechanismsProtein Kinase Regulation and GTPase Signaling

Serotonylation of small GTPases is a signal transduction pathway that triggers platelet α-granule release

Open access
Walther, Diego J, Peter, Jens-Uwe, Winter, Sandra, Höltje, Markus, Paulmann, Nils, Grohmann, Maik, Vowinckel, Jakob, Alamo-Bethencourt, Victor +3 more·2003·Cell

Abstract

Serotonin is a neurotransmitter in the central nervous system. In the periphery, serotonin functions as a ubiquitous hormone involved in vasoconstriction and platelet function. Serotonin is synthesized independently in peripheral tissues and neurons by two different rate-limiting tryptophan hydroxylase (TPH) isoenzymes. Here, we show that mice selectively deficient in peripheral TPH and serotonin exhibit impaired hemostasis, resulting in a reduced risk of thrombosis and thromboembolism, although the ultrastructure of the platelets is not affected. While the aggregation of serotonin-deficient platelets in vitro is apparently normal, their adhesion in vivo is reduced due to a blunted secretion of adhesive alpha-granular proteins. In elucidating the mechanism further, we demonstrate that serotonin is transamidated to small GTPases by transglutaminases during activation and aggregation of platelets, rendering these GTPases constitutively active. Our data provides evidence for a receptor-independent signaling mechanism, termed herein as "serotonylation," which leads to alpha-granule exocytosis from platelets.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0092-8674(03)01014-6

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Transglutamination of the Gln63 residue abolishes the intrinsic and GAP-stimulated GTPase activity of RhoA, leading to its permanent activation.

    “Finally, various types of transglutamination of the Gln63 residue have been found to abolish the intrinsic and GAP-stimulated GTPase activity of RhoA, leading to its permanent activation [74,75,76].”

    From RhoA Signaling in Neurodegenerative Diseases (2022) · cites this paper as [76]

    The Abstract says transamidation blocks intrinsic GTP-hydrolyzing activity and renders small GTPases constitutively active. The Results show that transamidated RhoA binds an effector strongly even when GDP-bound. Our copy does not establish that the modified residue is Gln63 or that GAP-stimulated GTPase activity is abolished. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 22

  1. [1]1. Aktories, K. ∙ Schmidt, G. ∙ Just, I. Rho GTPases as targets of bacterial protein toxins Biol. Chem. 2000; 381:421-426 Crossref Scopus (142) PubMed Google Scholar
  2. [2]2. Azim, A.C. ∙ Barkalow, K. ∙ Chou, J. ... Activation of the small GTPases, rac and cdc42, after ligation of the platelet PAR-1 receptor Blood. 2000; 95:959-964 Crossref PubMed Google Scholar
  3. [3]3. Azmitia, E.C. Modern views on an ancient chemicalserotonin effects on cell proliferation, maturation, and apoptosis Brain Res. Bull. 2001; 56:413-424 Crossref Scopus (422) PubMed Google Scholar
  4. [4]4. Barradas, M.A. ∙ Mikhailidis, D.P. ∙ Dandona, P. The effect of fenfluramine on collagen-induced platelet aggregation in vitro Br. J. Clin. Pharmacol. 1983; 16:459 Crossref Scopus (6) PubMed Google Scholar
  5. [5]5. Bodie, S.L. ∙ Ford, I. ∙ Greaves, M. ... Thrombin-induced activation of RhoA in platelet shape change Biochem. Biophys. Res. Commun. 2001; 287:71-76 Crossref Scopus (27) PubMed Google Scholar
  6. [6]6. Buczko, W. ∙ de Gaetano, G. ∙ Garratini, S. Efect of fenfluramine on 5-hydroxytryptamine uptake and release by rat blood platelets Br. J. Pharmacol. 1975; 53:563-568 Crossref Scopus (61) PubMed Google Scholar
  7. [7]7. Case, A. ∙ Stein, R.L. Kinetic analysis of the action of tissue transglutaminase on peptide and protein substrates Biochemistry. 2003; 42:9466-9481 Crossref Scopus (43) PubMed Google Scholar
  8. [8]8. Citron, B.A. ∙ Gregory, E.J. ∙ Steigerwalt, D.S. ... Regulation of the dual function tissue transglutaminase/Gαh during murine neuromuscular developmentgene and enzyme isoform expression Neurochem. Int. 2000; 37:337-349 Crossref Scopus (17) PubMed Google Scholar
  9. [9]9. Cohen, R.A. ∙ Shepherd, J.T. ∙ Vanhoutte, P.M. Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets Science. 1983; 221:273-274 Crossref Scopus (258) PubMed Google Scholar
  10. [10]10. Dale, G.L. ∙ Friese, P. ∙ Batar, P. ... Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface Nature. 2002; 415:175-179 Crossref Scopus (289) PubMed Google Scholar
  11. [11]11. De Clerk, F. ∙ Somers, Y. ∙ Van Gorp, L. Platelet-vessel wall interactions in hemostasisimplication of 5-hydroxytryptamine Agents Actions. 1984; 15:627-635 Crossref Scopus (18) PubMed Google Scholar
  12. [12]12. Denis, C. ∙ Methia, N. ∙ Frenette, P.S. ... A mouse model of severe von Willebrand diseasedefects in hemostasis and thrombosis Proc. Natl. Acad. Sci. USA. 1998; 95:9524-9529 Crossref Scopus (449) PubMed Google Scholar
  13. [13]13. Doye, A. ∙ Mettouchi, A. ∙ Bossis, G. ... CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion Cell. 2002; 111:553-564 Full Text Full Text (PDF) Scopus (243) PubMed Google Scholar
  14. [14]14. Eddahibi, S. ∙ Humbert, M. ∙ Fadel, E. ... Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension J. Clin. Invest. 2001; 108:1141-1150 Crossref Scopus (498) PubMed Google Scholar
  15. [15]15. Eddahibi, S. ∙ Raffestin, B. ∙ Hamon, M. ... Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension? J. Lab. Clin. Med. 2002; 139:194-201 Full Text Full Text (PDF) Scopus (68) PubMed Google Scholar
  16. [16]16. Greenberg, C.S. ∙ Birckbichler, P.J. ∙ Rice, R.H. Transglutaminasesmultifunctional cross-linking enzymes that stabilize tissues FASEB J. 1991; 5:3071-3077 Crossref Scopus (948) PubMed Google Scholar
  17. [17]17. Griffin, M. ∙ Casadio, R. ∙ Bergamini, C.M. Transglutaminasesnature's biological glues Biochem. J. 2002; 368:377-396 Crossref Scopus (911) PubMed Google Scholar
  18. [18]18. Höltje, M. ∙ Winter, S. ∙ Walther, D.J. ... The vesicular monoamine content regulates VMAT2 activity through Galphaq in mouse plateletsevidence for autoregulation of vesicular transmitter uptake J. Biol. Chem. 2003; 278:15850-15858 Crossref Scopus (53) PubMed Google Scholar
  19. [19]19. Holland, J.M. Serotonin deficiency and prolonged bleeding in beige mice Proc. Soc. Exp. Biol. Med. 1976; 151:32-39 Crossref Scopus (61) PubMed Google Scholar
  20. [20]20. Jackson, S.P. ∙ Nesbitt, W.S. ∙ Kulkarni, S. Signaling events underlying thrombus formation J. Thromb. Haemost. 2003; 1:1602-1612 Crossref Scopus (351) PubMed Google Scholar
  21. [21]21. Katayama, T. ∙ Ikeda, Y. ∙ Handa, M. ... Immunoneutralization of glycoprotein Ibα attenuates endotoxin-induced interactions of platelets and leukocytes with rat venular endothelium in vivo Circ. Res. 2000; 86:1031-1037 Crossref Scopus (77) PubMed Google Scholar
  22. [22]22. Killam, A.L. ∙ Cohen, M.L. Characterization of rat platelet serotonin receptors with tryptamine agonists and the antagonistsketanserin and SCH 23390 Thromb. Res. 1991; 64:331-339

Cited by

Sorted by citations

Authors
Walther, D. J., Peter, J.-U., Winter, S., Höltje, M., Paulmann, N., Grohmann, M., Vowinckel, J., Alamo-Bethencourt, V., Wilhelm, C. S., Ahnert-Hilger, G., & Bader, M.
Affiliations
  • Max Planck Institute for Molecular Genetics (DE)
  • Max Planck Society (DE)
  • Humboldt-Universität zu Berlin (DE)
  • Max Delbrück Center (DE)
Corresponding author
Walther, Diego J
Venue
Cell
Publisher
Elsevier BV
Published
2003-12
Volume
115
Issue
7
Pages
851-862
ISSN
0092-8674 (ISSN-L)
OpenAlex
W1968415875
Cited by
475
References
0
Citations by year
2026: 17 · 2025: 16 · 2024: 16 · 2023: 21 · 2022: 24 · 2021: 34 · 2020: 35 · 2019: 18 · 2018: 20 · 2017: 26 · 2016: 20 · 2015: 18 · 2014: 14 · 2013: 19 · 2012: 29
FWCI
5.01
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
  • Max Planck Institute for Plasma Physics (submittedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords
serotonin, serotonylation, small GTPases, transglutaminase, tryptophan hydroxylase, platelet adhesion, platelet aggregation, hemostasis, thrombosis, thromboembolism, receptor-independent signaling, exocytosis
MeSH terms
Animals, Bleeding Time, Blood Coagulation, Blood Platelets, Cell Adhesion, Cell Aggregation, Cytoplasm, Exocytosis, Factor VIII, Humans, Molecular Sequence Data, Transglutaminases, Serotonin, Thromboembolism, Tryptophan Hydroxylase, von Willebrand Factor, Signal Transduction, Sequence Homology, Amino Acid, Mice, Knockout, Calcium Signaling, GTP Phosphohydrolases, Secretory Vesicles, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review